Bringing Clinical Research to Practice
M.J. Powers & Co Publishers is accredited by the ACCME to provide continuing education for physicians. Our activities are also approved by the American Board of Psychiatry and Neurology (ABPN) for Maintenance of Certification (MOC).
- Provide optimum pharmacotherapy.
- Recognize, avoid, and manage drug side effects and interactions.
- Recognize consequences of drugs used in other areas of medicine.
- Provide safe and appropriate therapy.
- Diagnose, assess, and manage psychiatric and behavioral disorders.
- Identify risk factors and early interventions for psychiatric and behavioral disorders.
MJ Powers & Co publishes monthly newsletters about the efficacy and safety of drugs and therapeutics. The Alerts contain summaries, from a wide variety of journals, that can help you solve a problem, warn you about safety, or reassure you about efficacy. Not only will you receive the latest research findings, but also useful tools to help you judge research quality, evaluate study independence, and guide you with statistics.
The Alerts Newsletters are timely and thorough, and you can be assured of objectivity because MJ Powers & Co is independent. There is no sponsorship associated with any of our newsletters, and we accept no advertising. In addition, as a subscriber you will be eligible to enroll in our CME program, which your colleagues consistently rate as "excellent" and "practice changing".
Your Source for Fast, Easy CME Credits
Your Source for Fast, Easy CME Credits
Online guides to evidence-based practice that will help you:
You can earn credit using either the online interactive program or the traditional print format.
ONLINE SELF-ASSESSMENT PROGRAMS are also available with Psychiatry Drug Alerts and Child & Adolescent Psychiatry Alerts
Monthly Online CME
Monthly Online CME
Stimulant Warnings Updated
Updated product labeling will now be required to
include warnings that the agents should never be
shared, and the Boxed Warning will now describe
the risks of misuse, abuse, addiction, and overdose
consistently across all medicines in the class.
The Boxed Warning also will advise healthcare
professionals to monitor patients closely for signs
and symptoms of misuse, abuse, and addiction.